S&P 500
(-0.12%) 5 181.69 points
Dow Jones
(0.19%) 38 959 points
Nasdaq
(-0.29%) 16 285 points
Oil
(0.48%) $78.76
Gas
(-1.45%) $2.18
Gold
(0.00%) $2 324.30
Silver
(0.41%) $27.66
Platinum
(-0.42%) $984.25
USD/EUR
(0.10%) $0.930
USD/NOK
(0.06%) $10.91
USD/GBP
(0.09%) $0.800
USD/RUB
(0.18%) $91.60

リアルタイムの更新: Poly Medicure Limited [POLYMED.NS]

取引所: NSE セクター: Healthcare 産業: Medical Instruments & Supplies
最終更新日時8 5月 2024 @ 19:00

0.43% INR 1 605.50

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I...

Stats
本日の出来高 24 640.00
平均出来高 77 934.00
時価総額 154.08B
EPS INR0 ( 2024-02-02 )
次の収益日 ( INR0 ) 2024-05-17
Last Dividend INR3.00 ( 2023-09-21 )
Next Dividend INR0 ( N/A )
P/E 62.11
ATR14 INR2.61 (0.16%)

ボリューム 相関

長: 0.07 (neutral)
短: -0.99 (very strong negative)
Signal:(49.207) Neutral

Poly Medicure Limited 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Poly Medicure Limited 相関 - 通貨/商品

The country flag 0.23
( neutral )
The country flag 0.18
( neutral )
The country flag -0.27
( neutral )
The country flag -0.02
( neutral )
The country flag 0.53
( weak )
The country flag 0.55
( weak )

Poly Medicure Limited 財務諸表

Annual 2022
収益: INR11.15B
総利益: INR7.09B (63.61 %)
EPS: INR18.69
FY 2022
収益: INR11.15B
総利益: INR7.09B (63.61 %)
EPS: INR18.69
FY 2022
収益: INR9.17B
総利益: INR4.84B (52.75 %)
EPS: INR15.28
FY 2021
収益: INR7.75B
総利益: INR4.39B (56.59 %)
EPS: INR15.25

Financial Reports:

No articles found.

Poly Medicure Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR2.50
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR3.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Poly Medicure Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.15 - low (37.80%) | Divividend Growth Potential Score: 5.12 - Stable (2.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR0.375 2012-09-13
Last Dividend INR3.00 2023-09-21
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 15 --
Total Paid Out INR20.13 --
Avg. Dividend % Per Year 0.27% --
Score 2.15 --
Div. Sustainability Score 4.15
Div.Growth Potential Score 5.12
Div. Directional Score 4.63 --
Next Divdend (Est)
(2024-12-18)
INR3.29 Estimate 3.28 %
Dividend Stability
0.26 Very Poor
Dividend Score
2.15
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR2.00 0.80%
2019 INR2.00 0.90%
2020 INR2.00 0.92%
2021 INR2.50 0.49%
2022 INR2.50 0.26%
2023 INR3.00 0.33%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SIYSIL.NS Dividend Junior 2023-07-24 Semi-Annually 18 1.37%
MEDICAMEQ.NS Ex Dividend Junior 2023-09-20 Annually 3 0.02%
GULFOILLUB.NS Dividend Junior 2023-08-25 Annually 11 2.19%
BBTC.NS Dividend Junior 2023-09-22 Annually 22 0.08%
PRESTIGE.NS Dividend Junior 2023-09-14 Annually 14 0.25%
KANSAINER.NS Dividend Junior 2023-05-25 Annually 21 0.49%
EIHAHOTELS.NS Dividend Junior 2023-07-31 Sporadic 17 0.31%
ADVENZYMES.NS Dividend Junior 2023-08-04 Annually 8 0.59%
SUBROS.NS Dividend Junior 2023-08-22 Annually 20 0.22%
NAHARSPING.NS Dividend Junior 2023-09-08 Annually 18 0.74%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1911.5006.199.28[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1931.5008.9710.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM30.751.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM10.152.006.6210.00[0 - 30]
freeCashFlowPerShareTTM10.152.004.939.85[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6501.0002.502.50[0.2 - 0.8]
operatingProfitMarginTTM0.2481.0007.047.04[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score4.15

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM61.091.0003.930[1 - 100]
returnOnEquityTTM0.1932.509.3410.00[0.1 - 1.5]
freeCashFlowPerShareTTM10.152.006.629.85[0 - 30]
dividendYielPercentageTTM0.1891.5005.260[0 - 0.4]
operatingCashFlowPerShareTTM10.152.006.6210.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM310.521.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07461.000-0.6340[0.1 - 0.5]
Total Score5.12

Poly Medicure Limited

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。